Breaking News Instant updates and real-time market news.

PACW

PacWest Bancorp

$26.97 /

-0.58 (-2.11%)

07:12
07/07/22
07/07
07:12
07/07/22
07:12

PacWest Bancorp downgraded to Market Perform from Strong Buy at Raymond James

Raymond James analyst David Long downgraded PacWest Bancorp to Market Perform from Strong Buy without a price target. Long sees near-term headwinds for PacWest in the current operating backdrop and believes the bank has limited its asset sensitivity in the current rate hike cycle. The recent acquisition of Civic is a headwind in the near-term, as residential construction could slow considerably in the current operating backdrop, potentially resulting in credit losses in an asset class that is perceived to be higher risk, the analyst tells investors in a research note.

  • 21

    Jul

OTHER BREAKING NEWS FROM THE FLY

Earnings
Olaplex Holdings sees FY22 revenue $796M-$826M, consensus $822.98M » 06:57
08/09/22
08/09
06:57
08/09/22
06:57
OLPX

Olaplex Holdings

$16.29 /

+0.025 (+0.15%)

Sees FY22 Adjusted Net…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OLPX Olaplex Holdings
$16.29 /

+0.025 (+0.15%)

OLPX Olaplex Holdings
$16.29 /

+0.025 (+0.15%)

08/03/22 Barclays
Olaplex downgraded to Equal Weight from Overweight at Barclays
07/21/22 JPMorgan
Olaplex Holdings price target lowered to $21 from $23 at JPMorgan
06/16/22 Piper Sandler
Olaplex Holdings price target lowered to $24 from $26 at Piper Sandler
05/12/22 Cowen
Olaplex Holdings price target lowered to $22 from $33 at Cowen
OLPX Olaplex Holdings
$16.29 /

+0.025 (+0.15%)

  • 30
    Sep
OLPX Olaplex Holdings
$16.29 /

+0.025 (+0.15%)

OLPX Olaplex Holdings
$16.29 /

+0.025 (+0.15%)

Earnings
CareMax reports Q2 EPS (11c), consensus (5c) » 06:56
08/09/22
08/09
06:56
08/09/22
06:56
CMAX

CareMax

$6.96 /

-0.26 (-3.60%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CMAX CareMax
$6.96 /

-0.26 (-3.60%)

CMAX CareMax
$6.96 /

-0.26 (-3.60%)

05/11/22 Cowen
CareMax price target lowered to $8 from $11 at Cowen
01/07/22 UBS
CareMax initiated with a Buy at UBS
12/01/21 Piper Sandler
Piper Sandler remains buyer of CareMax after management meeting
11/15/21 Piper Sandler
Piper remains buyer of CareMax, likes share setup into Q4
CMAX CareMax
$6.96 /

-0.26 (-3.60%)

CMAX CareMax
$6.96 /

-0.26 (-3.60%)

CMAX CareMax
$6.96 /

-0.26 (-3.60%)

Earnings
Signet Jewelers cuts FY23 revenue view to $7.6B-$7.7B from $8.03B-$8.25B » 06:56
08/09/22
08/09
06:56
08/09/22
06:56
SIG

Signet Jewelers

$67.78 /

+4.135 (+6.50%)

Consensus $7.95B. The…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SIG Signet Jewelers
$67.78 /

+4.135 (+6.50%)

SIG Signet Jewelers
$67.78 /

+4.135 (+6.50%)

06/10/22 UBS
Signet Jewelers price target lowered to $120 from $138 at UBS
06/10/22 Citi
Signet Jewelers price target lowered to $76 from $94 at Citi
04/05/22 Wells Fargo
Signet Jewelers price target lowered to $105 from $140 at Wells Fargo
03/18/22 Citi
Signet Jewelers price target raised to $94 from $90 at Citi
SIG Signet Jewelers
$67.78 /

+4.135 (+6.50%)

SIG Signet Jewelers
$67.78 /

+4.135 (+6.50%)

SIG Signet Jewelers
$67.78 /

+4.135 (+6.50%)

Downgrade
Quanterix downgraded to Market Perform from Outperform at SVB Securities » 06:56
08/09/22
08/09
06:56
08/09/22
06:56
QTRX

Quanterix

$16.47 /

-1.01 (-5.78%)

SVB Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
QTRX Quanterix
$16.47 /

-1.01 (-5.78%)

QTRX Quanterix
$16.47 /

-1.01 (-5.78%)

05/11/22 Cowen
Quanterix price target lowered to $38 from $60 at Cowen
03/15/22 BTIG
Quanterix price target lowered to $60 from $92 at BTIG
03/02/22 Goldman Sachs
Quanterix upgraded to Neutral from Sell at Goldman Sachs
10/14/21 Cowen
Quanterix coverage transferred at Cowen
QTRX Quanterix
$16.47 /

-1.01 (-5.78%)

QTRX Quanterix
$16.47 /

-1.01 (-5.78%)

Earnings
Olaplex Holdings reports Q2 adjusted EPS 14c, consensus 13c » 06:55
08/09/22
08/09
06:55
08/09/22
06:55
OLPX

Olaplex Holdings

$16.29 /

+0.025 (+0.15%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OLPX Olaplex Holdings
$16.29 /

+0.025 (+0.15%)

OLPX Olaplex Holdings
$16.29 /

+0.025 (+0.15%)

08/03/22 Barclays
Olaplex downgraded to Equal Weight from Overweight at Barclays
07/21/22 JPMorgan
Olaplex Holdings price target lowered to $21 from $23 at JPMorgan
06/16/22 Piper Sandler
Olaplex Holdings price target lowered to $24 from $26 at Piper Sandler
05/12/22 Cowen
Olaplex Holdings price target lowered to $22 from $33 at Cowen
OLPX Olaplex Holdings
$16.29 /

+0.025 (+0.15%)

  • 30
    Sep
OLPX Olaplex Holdings
$16.29 /

+0.025 (+0.15%)

OLPX Olaplex Holdings
$16.29 /

+0.025 (+0.15%)

Earnings
Emerson Electric reports Q3 adjusted EPS $1.38, consensus $1.30 » 06:55
08/09/22
08/09
06:55
08/09/22
06:55
EMR

Emerson Electric

$90.03 /

-0.375 (-0.41%)

Reports Q3 revenue $5B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EMR Emerson Electric
$90.03 /

-0.375 (-0.41%)

EMR Emerson Electric
$90.03 /

-0.375 (-0.41%)

07/18/22 Mizuho
Emerson Electric price target lowered to $85 from $100 at Mizuho
07/13/22 Deutsche Bank
Emerson Electric price target lowered to $97 from $110 at Deutsche Bank
07/12/22 Wells Fargo
Emerson Electric price target raised to $89 from $87 at Wells Fargo
07/08/22 Barclays
Emerson Electric price target lowered to $80 from $87 at Barclays
EMR Emerson Electric
$90.03 /

-0.375 (-0.41%)

EMR Emerson Electric
$90.03 /

-0.375 (-0.41%)

EMR Emerson Electric
$90.03 /

-0.375 (-0.41%)

Recommendations
Acadia Pharmaceuticals price target lowered to $21 from $26 at RBC Capital » 06:54
08/09/22
08/09
06:54
08/09/22
06:54
ACAD

Acadia Pharmaceuticals

$16.65 /

+0.225 (+1.37%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ACAD Acadia Pharmaceuticals
$16.65 /

+0.225 (+1.37%)

ACAD Acadia Pharmaceuticals
$16.65 /

+0.225 (+1.37%)

06:36 Today Mizuho
Acadia Pharmaceuticals price target lowered to $19 from $27 at Mizuho
06:23 Today H.C. Wainwright
Acadia Pharmaceuticals price target raised to $25 from $20 at H.C. Wainwright
05:40 Today Citi
Acadia Pharmaceuticals price target raised to $17 from $15 at Citi
08/08/22 Cowen
Acadia Pharmaceuticals price target lowered to $21 from $32 at Cowen
ACAD Acadia Pharmaceuticals
$16.65 /

+0.225 (+1.37%)

ACAD Acadia Pharmaceuticals
$16.65 /

+0.225 (+1.37%)

ACAD Acadia Pharmaceuticals
$16.65 /

+0.225 (+1.37%)

Earnings
ChannelAdvisor sees FY22 revenue $177M-$179M, consensus $177.99M  06:54
08/09/22
08/09
06:54
08/09/22
06:54
ECOM

ChannelAdvisor

$15.49 /

+0.53 (+3.54%)

 
ShowHide Related Items >><<
ECOM ChannelAdvisor
$15.49 /

+0.53 (+3.54%)

ECOM ChannelAdvisor
$15.49 /

+0.53 (+3.54%)

06/29/22 B. Riley
ChannelAdvisor risk/reward skews to the upside, says B. Riley
05/09/22 B. Riley
ChannelAdvisor price target lowered to $24 from $32 at B. Riley
02/11/22 Needham
ChannelAdvisor price target lowered to $26 from $35 at Needham
02/02/22 B. Riley
ChannelAdvisor price target lowered to $32 from $38 at B. Riley
ECOM ChannelAdvisor
$15.49 /

+0.53 (+3.54%)

Recommendations
Palantir price target lowered to $11 from $13 at Morgan Stanley » 06:54
08/09/22
08/09
06:54
08/09/22
06:54
PLTR

Palantir

$9.82 /

-1.625 (-14.20%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PLTR Palantir
$9.82 /

-1.625 (-14.20%)

PLTR Palantir
$9.82 /

-1.625 (-14.20%)

05:38 Today Citi
Palantir price target lowered to $6 from $7 at Citi
05:18 Today Deutsche Bank
Palantir downgraded to Sell from Hold at Deutsche Bank
08/08/22 Jefferies
Palantir price target lowered to $12 from $13 at Jefferies
08/03/22 RBC Capital
U.S. federal spending tracker 'worrisome' for Palantir, says RBC Capital
PLTR Palantir
$9.82 /

-1.625 (-14.20%)

PLTR Palantir
$9.82 /

-1.625 (-14.20%)

PLTR Palantir
$9.82 /

-1.625 (-14.20%)

PLTR Palantir
$9.82 /

-1.625 (-14.20%)

Earnings
IAA sees FY22 revenue $2.020B-$2.075B, consensus $2.1B » 06:54
08/09/22
08/09
06:54
08/09/22
06:54
IAA

IAA

$38.26 /

+0.54 (+1.43%)

FY22 revenue view…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IAA IAA
$38.26 /

+0.54 (+1.43%)

IAA IAA
$38.26 /

+0.54 (+1.43%)

06/09/22 Guggenheim
IAA upgraded to Buy from Neutral at Guggenheim
05/10/22 Barrington
IAA upgraded to Outperform at Barrington after better-than-expected Q1
05/10/22 Barrington
IAA upgraded to Outperform from Market Perform at Barrington
03/15/22 Stephens
Stephens agrees with activist that IAA undervalued
IAA IAA
$38.26 /

+0.54 (+1.43%)

Earnings
ChannelAdvisor sees Q3 revenue $43.4M-$43.8M, consensus $44.28M  06:54
08/09/22
08/09
06:54
08/09/22
06:54
ECOM

ChannelAdvisor

$15.49 /

+0.53 (+3.54%)

 
ShowHide Related Items >><<
ECOM ChannelAdvisor
$15.49 /

+0.53 (+3.54%)

ECOM ChannelAdvisor
$15.49 /

+0.53 (+3.54%)

06/29/22 B. Riley
ChannelAdvisor risk/reward skews to the upside, says B. Riley
05/09/22 B. Riley
ChannelAdvisor price target lowered to $24 from $32 at B. Riley
02/11/22 Needham
ChannelAdvisor price target lowered to $26 from $35 at Needham
02/02/22 B. Riley
ChannelAdvisor price target lowered to $32 from $38 at B. Riley
ECOM ChannelAdvisor
$15.49 /

+0.53 (+3.54%)

Hot Stocks
Signet Jewelers to acquire Blue Nile for $360M in cash, sees accretion in FY24 » 06:54
08/09/22
08/09
06:54
08/09/22
06:54
SIG

Signet Jewelers

$67.78 /

+4.135 (+6.50%)

Signet Jewelers announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SIG Signet Jewelers
$67.78 /

+4.135 (+6.50%)

SIG Signet Jewelers
$67.78 /

+4.135 (+6.50%)

06/10/22 UBS
Signet Jewelers price target lowered to $120 from $138 at UBS
06/10/22 Citi
Signet Jewelers price target lowered to $76 from $94 at Citi
04/05/22 Wells Fargo
Signet Jewelers price target lowered to $105 from $140 at Wells Fargo
03/18/22 Citi
Signet Jewelers price target raised to $94 from $90 at Citi
SIG Signet Jewelers
$67.78 /

+4.135 (+6.50%)

SIG Signet Jewelers
$67.78 /

+4.135 (+6.50%)

SIG Signet Jewelers
$67.78 /

+4.135 (+6.50%)

Recommendations
uniQure price target lowered to $24 from $34 at Wells Fargo » 06:53
08/09/22
08/09
06:53
08/09/22
06:53
QURE

uniQure

$18.60 /

-6.92 (-27.12%)

Wells Fargo analyst Jim…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
QURE uniQure
$18.60 /

-6.92 (-27.12%)

QURE uniQure
$18.60 /

-6.92 (-27.12%)

06:21 Today H.C. Wainwright
uniQure selloff brings attractive entry point, says H.C. Wainwright
08/08/22 Chardan
uniQure price target lowered to $60 from $65 at Chardan
08/08/22 Truist
uniQure's high-dose HD data still on track for 1H23, says Truist
05/05/22 Stifel
uniQure price target lowered to $37 from $66 at Stifel
QURE uniQure
$18.60 /

-6.92 (-27.12%)

QURE uniQure
$18.60 /

-6.92 (-27.12%)

Earnings
ChannelAdvisor reports Q2 EPS 6c, consensus 15c » 06:53
08/09/22
08/09
06:53
08/09/22
06:53
ECOM

ChannelAdvisor

$15.49 /

+0.53 (+3.54%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ECOM ChannelAdvisor
$15.49 /

+0.53 (+3.54%)

ECOM ChannelAdvisor
$15.49 /

+0.53 (+3.54%)

06/29/22 B. Riley
ChannelAdvisor risk/reward skews to the upside, says B. Riley
05/09/22 B. Riley
ChannelAdvisor price target lowered to $24 from $32 at B. Riley
02/11/22 Needham
ChannelAdvisor price target lowered to $26 from $35 at Needham
02/02/22 B. Riley
ChannelAdvisor price target lowered to $32 from $38 at B. Riley
ECOM ChannelAdvisor
$15.49 /

+0.53 (+3.54%)

Recommendations
Accenture price target raised to $338 from $310 at Baird » 06:52
08/09/22
08/09
06:52
08/09/22
06:52
ACN

Accenture

$310.24 /

+0.915 (+0.30%)

Baird analyst David…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ACN Accenture
$310.24 /

+0.915 (+0.30%)

ACN Accenture
$310.24 /

+0.915 (+0.30%)

07/18/22 Piper Sandler
Accenture price target lowered to $281 from $305 at Piper Sandler
06/29/22 Exane BNP Paribas
Accenture downgraded to Neutral from Outperform at Exane BNP Paribas
06/25/22 Barclays
Accenture price target lowered to $370 from $455 at Barclays
06/24/22 RBC Capital
Accenture price target lowered to $357 from $435 at RBC Capital
ACN Accenture
$310.24 /

+0.915 (+0.30%)

ACN Accenture
$310.24 /

+0.915 (+0.30%)

ACN Accenture
$310.24 /

+0.915 (+0.30%)

Recommendations
ShockWave Medical price target raised to $255 from $176 at Wells Fargo » 06:52
08/09/22
08/09
06:52
08/09/22
06:52
SWAV

ShockWave Medical

$221.92 /

-0.94 (-0.42%)

Wells Fargo analyst Larry…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SWAV ShockWave Medical
$221.92 /

-0.94 (-0.42%)

SWAV ShockWave Medical
$221.92 /

-0.94 (-0.42%)

04:53 Today Piper Sandler
ShockWave Medical price target raised to $278 from $245 at Piper Sandler
05/23/22 Piper Sandler
ShockWave Medical's China approval adds growth driver, says Piper Sandler
05/10/22 Canaccord
ShockWave Medical price target lowered to $190 from $221 at Canaccord
05/10/22 Wells Fargo
ShockWave Medical price target lowered to $176 from $235 at Wells Fargo
SWAV ShockWave Medical
$221.92 /

-0.94 (-0.42%)

SWAV ShockWave Medical
$221.92 /

-0.94 (-0.42%)

Hot Stocks
Moderna amends Covid-19 vaccine agreement with EC » 06:52
08/09/22
08/09
06:52
08/09/22
06:52
MRNA

Moderna

$183.08 /

-3.71 (-1.99%)

Moderna announced an…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRNA Moderna
$183.08 /

-3.71 (-1.99%)

MRNA Moderna
$183.08 /

-3.71 (-1.99%)

06/29/22 Evercore ISI
Icosavax upgraded to Outperform at Evercore on 'competitive' RSV vaccine data
06/14/22 Piper Sandler
Piper Sandler confident in positive VRBPAC opinion for Moderna's SpikeVax
06/13/22 Morgan Stanley
Moderna pediatric EUA vaccine briefing docs 'clean,' says Morgan Stanley
05/17/22 Piper Sandler
Moderna price target lowered to $214 from $348 at Piper Sandler
MRNA Moderna
$183.08 /

-3.71 (-1.99%)

MRNA Moderna
$183.08 /

-3.71 (-1.99%)

MRNA Moderna
$183.08 /

-3.71 (-1.99%)

MRNA Moderna
$183.08 /

-3.71 (-1.99%)

Earnings
International Seaways reports Q2 adjusted EPS $1.43, consensus $1.19 » 06:51
08/09/22
08/09
06:51
08/09/22
06:51
INSW

International Seaways

$25.40 /

+0.61 (+2.46%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
INSW International Seaways
$25.40 /

+0.61 (+2.46%)

INSW International Seaways
$25.40 /

+0.61 (+2.46%)

07/27/22 BTIG
International Seaways upgraded to Buy from Neutral at BTIG
07/20/22 Jefferies
International Seaways initiated with a Buy at Jefferies
07/19/22 Stifel
International Seaways price target raised to $31 from $27 at Stifel
07/06/22 B. Riley
Tanker stocks have more room to run, says B. Riley
INSW International Seaways
$25.40 /

+0.61 (+2.46%)

INSW International Seaways
$25.40 /

+0.61 (+2.46%)

Downgrade
Global Blood Therapeutics downgraded to Equal Weight from Overweight at Wells Fargo » 06:50
08/09/22
08/09
06:50
08/09/22
06:50
GBT

Global Blood Therapeutics

$66.58 /

+2.77 (+4.34%)

, PFE

Pfizer

$49.55 /

+0.29 (+0.59%)

Wells Fargo analyst Jim…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GBT Global Blood Therapeutics
$66.58 /

+2.77 (+4.34%)

PFE Pfizer
$49.55 /

+0.29 (+0.59%)

GBT Global Blood Therapeutics
$66.58 /

+2.77 (+4.34%)

08/08/22 Cantor Fitzgerald
Global Blood downgraded to Neutral from Overweight at Cantor Fitzgerald
08/08/22 RBC Capital
Global Blood downgraded to Sector Perform from Outperform at RBC Capital
08/08/22 Cowen
Global Blood Therapeutics downgraded to Market Perform from Outperform at Cowen
08/08/22 Guggenheim
Global Blood Therapeutics downgraded to Neutral from Buy at Guggenheim
PFE Pfizer
$49.55 /

+0.29 (+0.59%)

08/08/22 Cantor Fitzgerald
Global Blood downgraded to Neutral from Overweight at Cantor Fitzgerald
08/08/22 Oppenheimer
Global Blood Therapeutics downgraded to Perform from Outperform at Oppenheimer
08/08/22 Stifel
Global Blood Therapeutics downgraded to Hold from Buy at Stifel
08/08/22 Piper Sandler
Global Blood takeover by Pfizer 'solid outcome,' says Piper Sandler
GBT Global Blood Therapeutics
$66.58 /

+2.77 (+4.34%)

PFE Pfizer
$49.55 /

+0.29 (+0.59%)

GBT Global Blood Therapeutics
$66.58 /

+2.77 (+4.34%)

PFE Pfizer
$49.55 /

+0.29 (+0.59%)

GBT Global Blood Therapeutics
$66.58 /

+2.77 (+4.34%)

PFE Pfizer
$49.55 /

+0.29 (+0.59%)

PFE Pfizer
$49.55 /

+0.29 (+0.59%)

Earnings
IAA reports Q2 adjusted EPS 62c, consensus 57c » 06:50
08/09/22
08/09
06:50
08/09/22
06:50
IAA

IAA

$38.26 /

+0.54 (+1.43%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
IAA IAA
$38.26 /

+0.54 (+1.43%)

IAA IAA
$38.26 /

+0.54 (+1.43%)

06/09/22 Guggenheim
IAA upgraded to Buy from Neutral at Guggenheim
05/10/22 Barrington
IAA upgraded to Outperform at Barrington after better-than-expected Q1
05/10/22 Barrington
IAA upgraded to Outperform from Market Perform at Barrington
03/15/22 Stephens
Stephens agrees with activist that IAA undervalued
IAA IAA
$38.26 /

+0.54 (+1.43%)

Earnings
Target Hospitality reports Q2 EPS 24c, consensus 17c » 06:49
08/09/22
08/09
06:49
08/09/22
06:49
TH

Target Hospitality

$13.97 /

+0.12 (+0.87%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TH Target Hospitality
$13.97 /

+0.12 (+0.87%)

TH Target Hospitality
$13.97 /

+0.12 (+0.87%)

07/12/22 Oppenheimer
Target Hospitality price target raised to $18 from $9 at Oppenheimer
TH Target Hospitality
$13.97 /

+0.12 (+0.87%)

TH Target Hospitality
$13.97 /

+0.12 (+0.87%)

Recommendations
Enanta price target raised to $137 from $103 at JMP Securities » 06:49
08/09/22
08/09
06:49
08/09/22
06:49
ENTA

Enanta

$71.21 /

+0.39 (+0.55%)

JMP Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ENTA Enanta
$71.21 /

+0.39 (+0.55%)

ENTA Enanta
$71.21 /

+0.39 (+0.55%)

08/01/22 Oppenheimer
Enanta price target raised to $53 from $45 at Oppenheimer
07/29/22 Piper Sandler
Enanta's 'strong' EDP-235 data supports 'impressive' profile, says Piper Sandler
07/06/22 Evercore ISI
Enanta upgraded to Outperform at Evercore ISI ahead of COVID anti-viral data
07/06/22 Evercore ISI
Enanta upgraded to Outperform from In Line at Evercore ISI
ENTA Enanta
$71.21 /

+0.39 (+0.55%)

ENTA Enanta
$71.21 /

+0.39 (+0.55%)

Earnings
Capri Holdings sees FY23 EPS $6.85, consensus $6.74 » 06:49
08/09/22
08/09
06:49
08/09/22
06:49
CPRI

Capri Holdings

$51.01 /

+1.38 (+2.78%)

Sees FY23 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CPRI Capri Holdings
$51.01 /

+1.38 (+2.78%)

CPRI Capri Holdings
$51.01 /

+1.38 (+2.78%)

07/28/22 Barclays
Capri Holdings price target raised to $66 from $63 at Barclays
07/21/22 Credit Suisse
Capri Holdings price target lowered to $56 from $65 at Credit Suisse
07/21/22 Goldman Sachs
Capri Holdings price target lowered to $59 from $69 at Goldman Sachs
07/15/22 UBS
Capri Holdings price target lowered to $65 from $91 at UBS
CPRI Capri Holdings
$51.01 /

+1.38 (+2.78%)

CPRI Capri Holdings
$51.01 /

+1.38 (+2.78%)

CPRI Capri Holdings
$51.01 /

+1.38 (+2.78%)

Recommendations
Tyson Foods price target lowered to $95 from $100 at Stephens » 06:49
08/09/22
08/09
06:49
08/09/22
06:49
TSN

Tyson Foods

$80.10 /

-7.395 (-8.45%)

Stephens analyst Ben…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TSN Tyson Foods
$80.10 /

-7.395 (-8.45%)

TSN Tyson Foods
$80.10 /

-7.395 (-8.45%)

06:16 Today BMO Capital
Tyson Foods price target lowered to $90 from $99 at BMO Capital
05:55 Today Barclays
Tyson Foods price target lowered to $89 from $100 at Barclays
04:57 Today Piper Sandler
Piper upgrades Tyson Foods to Neutral with risks priced in
08/08/22 Piper Sandler
Tyson Foods upgraded to Neutral from Underweight at Piper Sandler
TSN Tyson Foods
$80.10 /

-7.395 (-8.45%)

TSN Tyson Foods
$80.10 /

-7.395 (-8.45%)

TSN Tyson Foods
$80.10 /

-7.395 (-8.45%)

TSN Tyson Foods
$80.10 /

-7.395 (-8.45%)

Recommendations
Reata Pharmaceuticals price target lowered to $27 from $37 at Baird » 06:49
08/09/22
08/09
06:49
08/09/22
06:49
RETA

Reata Pharmaceuticals

$24.02 /

-11.895 (-33.12%)

Baird analyst Brian…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RETA Reata Pharmaceuticals
$24.02 /

-11.895 (-33.12%)

RETA Reata Pharmaceuticals
$24.02 /

-11.895 (-33.12%)

08/08/22 Goldman Sachs
Reata sinks on Friedreich's ataxia update but Goldman remains positive
08/08/22 Goldman Sachs
Reata Pharmaceuticals price target raised to $76 from $73 at Goldman Sachs
05/27/22 Citi
Reata Pharmaceuticals price target raised to $46 from $43 at Citi
05/11/22 Ladenburg
Reata Pharmaceuticals price target lowered to $67 from $75 at Ladenburg
RETA Reata Pharmaceuticals
$24.02 /

-11.895 (-33.12%)

RETA Reata Pharmaceuticals
$24.02 /

-11.895 (-33.12%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.